Synchrony Finl (NYSE:SYF) reported its Q2 earnings results on Monday, July 18, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
– On primary efficacy and key secondary endpoints, TransCon hGH demonstrated statistically significant reduction from baseline in trunk fat and increase in total body lean mass at Week 38 compared to placebo